CD39/CD73 recombinant anti-inflammatory fusion protein (Arthrogen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD39/CD73 recombinant anti-inflammatory fusion protein (Arthrogen)
Drug Alias NameCD39/CD73 RAIN protein (Arthrogen)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of Action5'-nucleotidase stimulantsEctonucleoside triphosphate diphosphohydrolase 1 agonists
TargetsEctonucleoside triphosphate diphosphohydrolase 15'-nucleotidase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArthrogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArthrogen
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A